2-[[1-(4-methoxyphenyl)-3-methylpyrazolo[5,4-d][1,3]thiazol-5-yl]-methylamino]-N-(3-pyrrolidin-1-ylpropyl)acetamide

C22H30N6O2S — CID 53195679

IUPAC2-[[1-(4-methoxyphenyl)-3-methylpyrazolo[5,4-d][1,3]thiazol-5-yl]-methylamino]-N-(3-pyrrolidin-1-ylpropyl)acetamide
SMILESCOc1ccc(-n2nc(C)c3sc(N(C)CC(=O)NCCCN4CCCC4)nc32)cc1
InChIInChI=1S/C22H30N6O2S/c1-16-20-21(28(25-16)17-7-9-18(30-3)10-8-17)24-22(31-20)26(2)15-19(29)23-11-6-14-27-12-4-5-13-27/h7-10H,4-6,11-15H2,1-3H3,(H,23,29)
InChIKeyYDTJWRVNFIWGIQ-UHFFFAOYSA-N
MW442.59 g/mol
LogP2.84
Rot. Bonds9

About 2-[[1-(4-methoxyphenyl)-3-methylpyrazolo[5,4-d][1,3]thiazol-5-yl]-methylamino]-N-(3-pyrrolidin-1-ylpropyl)acetamide

2-[[1-(4-methoxyphenyl)-3-methylpyrazolo[5,4-d][1,3]thiazol-5-yl]-methylamino]-N-(3-pyrrolidin-1-ylpropyl)acetamide (PubChem CID 53195679) has the molecular formula C22H30N6O2S and a molecular weight of 442.59 g/mol. Its IUPAC name is 2-[[1-(4-methoxyphenyl)-3-methylpyrazolo[5,4-d][1,3]thiazol-5-yl]-methylamino]-N-(3-pyrrolidin-1-ylpropyl)acetamide.

Molecular Properties

Compound Name2-[[1-(4-methoxyphenyl)-3-methylpyrazolo[5,4-d][1,3]thiazol-5-yl]-methylamino]-N-(3-pyrrolidin-1-ylpropyl)acetamide
PubChem CID53195679
Molecular FormulaC22H30N6O2S
Molecular Weight442.59 g/mol
Exact Mass442.22
IUPAC Name2-[[1-(4-methoxyphenyl)-3-methylpyrazolo[5,4-d][1,3]thiazol-5-yl]-methylamino]-N-(3-pyrrolidin-1-ylpropyl)acetamide
SMILESCOc1ccc(-n2nc(C)c3sc(N(C)CC(=O)NCCCN4CCCC4)nc32)cc1
InChIInChI=1S/C22H30N6O2S/c1-16-20-21(28(25-16)17-7-9-18(30-3)10-8-17)24-22(31-20)26(2)15-19(29)23-11-6-14-27-12-4-5-13-27/h7-10H,4-6,11-15H2,1-3H3,(H,23,29)
InChIKeyYDTJWRVNFIWGIQ-UHFFFAOYSA-N
XLogP2.84
TPSA75.52 Ų
H-Bond Donors1
H-Bond Acceptors8
Rotatable Bonds9
Heavy Atoms31
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500442.59
LogP ≤ 52.84
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 108

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}

Analyze 2-[[1-(4-methoxyphenyl)-3-methylpyrazolo[5,4-d][1,3]thiazol-5-yl]-methylamino]-N-(3-pyrrolidin-1-ylpropyl)acetamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 2-[[1-(4-methoxyphenyl)-3-methylpyrazolo[5,4-d][1,3]thiazol-5-yl]-methylamino]-N-(3-pyrrolidin-1-ylpropyl)acetamide?
The IUPAC name of 2-[[1-(4-methoxyphenyl)-3-methylpyrazolo[5,4-d][1,3]thiazol-5-yl]-methylamino]-N-(3-pyrrolidin-1-ylpropyl)acetamide (CID 53195679) is 2-[[1-(4-methoxyphenyl)-3-methylpyrazolo[5,4-d][1,3]thiazol-5-yl]-methylamino]-N-(3-pyrrolidin-1-ylpropyl)acetamide.
What is the SMILES notation for 2-[[1-(4-methoxyphenyl)-3-methylpyrazolo[5,4-d][1,3]thiazol-5-yl]-methylamino]-N-(3-pyrrolidin-1-ylpropyl)acetamide?
The canonical SMILES for 2-[[1-(4-methoxyphenyl)-3-methylpyrazolo[5,4-d][1,3]thiazol-5-yl]-methylamino]-N-(3-pyrrolidin-1-ylpropyl)acetamide is COc1ccc(-n2nc(C)c3sc(N(C)CC(=O)NCCCN4CCCC4)nc32)cc1.
What is the InChIKey of 2-[[1-(4-methoxyphenyl)-3-methylpyrazolo[5,4-d][1,3]thiazol-5-yl]-methylamino]-N-(3-pyrrolidin-1-ylpropyl)acetamide?
The InChIKey is YDTJWRVNFIWGIQ-UHFFFAOYSA-N. The full InChI is InChI=1S/C22H30N6O2S/c1-16-20-21(28(25-16)17-7-9-18(30-3)10-8-17)24-22(31-20)26(2)15-19(29)23-11-6-14-27-12-4-5-13-27/h7-10H,4-6,11-15H2,1-3H3,(H,23,29).
What are the key properties of 2-[[1-(4-methoxyphenyl)-3-methylpyrazolo[5,4-d][1,3]thiazol-5-yl]-methylamino]-N-(3-pyrrolidin-1-ylpropyl)acetamide?
2-[[1-(4-methoxyphenyl)-3-methylpyrazolo[5,4-d][1,3]thiazol-5-yl]-methylamino]-N-(3-pyrrolidin-1-ylpropyl)acetamide has a molecular weight of 442.59 g/mol, XLogP of 2.84, 9 rotatable bonds, 1 hydrogen bond donors, and 8 hydrogen bond acceptors.
Where does this data come from?
All data for 2-[[1-(4-methoxyphenyl)-3-methylpyrazolo[5,4-d][1,3]thiazol-5-yl]-methylamino]-N-(3-pyrrolidin-1-ylpropyl)acetamide is sourced from PubChem (CID 53195679), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).